학술논문
SO-22 Gut microbiome composition as predictor of the efficacy of adding atezolizumab to first-line FOLFOXIRI plus bevacizumab in metastatic colorectal cancer: A translational analysis of the AtezoTRIBE study
Document Type
Abstract
Author
Source
In Annals of Oncology June 2023 34 Supplement 1:S171-S171
Subject
Language
ISSN
0923-7534